Background
The purpose of this study is to evaluate the effect of oxycodone and sufentanil on postoperative analgesia and immune function in patients with laparoscopic resection of colorectal cancer (CRC), as well as the serum level of inflammatory cytokine.
Methods
40 patients from August 2023 to August 2024 in Shenzhen Nanshan Hospital undergoing laparoscopic resection of CRC were randomly divided into Group O (n = 20) and Group S (n = 20). The visual analog scale (VAS) score and serial blood samples were assessed during perioperative period. The primary outcome was VAS scores and immune function at 24h and 72h after surgery. The secondary outcome was inflammatory markers at 24h and 72h after surgery.
Results
The VAS scores at cough in Group O at 24 h and 72h postoperative were lower than those in Group S (p < 0.001). No significant difference was found in VAS scores at rest between the two groups (P > 0.05). The immune indicators including C3, C4, IgG, IgA, IgE, IgM, CD3+, CD4+, CD8+ and CD4+/CD8+did not show significant changes after using oxycodone or sufentanil for patient-controlled intravenous analgesia (PCIA). There was no significant difference in inflammatory factors (including IL-2, IL-4, IL-6, IL-10, TNF-a and INF-y) at 24 h and 72h after surgery between the Group O and Group S.
Conclusion
The effect of oxycodone in relieving visceral pain is better than sufentanil, but not cutting pain. In addition, there is no significant superiority in the effects of oxycodone on immune function and inflammatory cytokine release compared to sufentanil.
Trial registration
Chinese Clinical Trial Registry (ChiCTR2400089072).